Prilosec OTC impacting Protonix?
This article was originally published in The Tan Sheet
Executive Summary
Wyeth reiterates Procter & Gamble's recent launch of Prilosec OTC (omeprazole) will not impact sales of its Rx GERD treatment Protonix (pantoprazole sodium) (1"The Tan Sheet" July 28, 2003, p. 11). During Bear Stearns Healthcare Conference in New York City Sept. 9, Wyeth North America President Joseph Mahady notes "the change in market status from a single omeprazole generic to now having multiple generics...will more than likely have the most significant change on the market. In our opinion that will be more critical to the performance of Protonix in the future than will be the availability of an OTC version of Prilosec"...